SpyGlass Pharma (SGP) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SI-BONE is the larger company by market cap ($845.3 million vs $823.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SGP | SIBN |
|---|---|---|
| Share price | $24.62 | $18.86 |
| Market cap | $823.49M | $845.28M |
| 1-day change | +3.01% | -1.26% |
| YTD return | — | -4.36% |
| 1-year return | — | +24.00% |
| 5-year return | — | -17.46% |
| EPS (TTM) | $-2.58 | $-0.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.44 | $21.89 |
| 52-week low | $17.06 | $11.48 |
| Distance from 52-week high | -24.11% | -13.84% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +78.72% | +33.72% |
| Average volume | 110.00K | 543.48K |
| Shares outstanding | 33.45M | 44.82M |
| Employees | 76 | 376 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 76 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
SGP vs SIBN FAQ
Which is bigger, SpyGlass Pharma or SI-BONE?
SI-BONE (SIBN) is larger, with a market capitalization of $845.28M compared with $823.49M for SpyGlass Pharma (SGP).
Are SpyGlass Pharma and SI-BONE in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.